Correlation Between Pharvaris and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Aerovate Therapeutics, you can compare the effects of market volatilities on Pharvaris and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Aerovate Therapeutics.
Diversification Opportunities for Pharvaris and Aerovate Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pharvaris and Aerovate is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Pharvaris i.e., Pharvaris and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Pharvaris and Aerovate Therapeutics
Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the Aerovate Therapeutics. In addition to that, Pharvaris is 1.14 times more volatile than Aerovate Therapeutics. It trades about -0.32 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.19 per unit of volatility. If you would invest 258.00 in Aerovate Therapeutics on November 30, 2024 and sell it today you would lose (16.00) from holding Aerovate Therapeutics or give up 6.2% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Pharvaris BV vs. Aerovate Therapeutics
Performance |
Timeline |
Pharvaris BV |
Aerovate Therapeutics |
Pharvaris and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pharvaris and Aerovate Therapeutics
The main advantage of trading using opposite Pharvaris and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.Pharvaris vs. Pmv Pharmaceuticals | ||
Pharvaris vs. MediciNova | ||
Pharvaris vs. PepGen | ||
Pharvaris vs. Molecular Partners AG |
Aerovate Therapeutics vs. Adagene | ||
Aerovate Therapeutics vs. Acrivon Therapeutics, Common | ||
Aerovate Therapeutics vs. Rezolute | ||
Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |